LiveSpo Global, formerly known as ANABIO R&D, was founded in 2010, by a group of 3 founders, with proprietary technology developed by Dr. Nguyen Hoa Anh. After 15 years of studying and working in molecular biology at Tohoku University, Japan, Dr. Nguyen Hoa Anh returned to Vietnam in 2010.

After months working around the clock, in 2013, the first commercial spore-based probiotics in water form was launched. This technology surpassed all the disadvantages of traditional probiotics: multi-strains, high concentration, resistant to temperature up to 80oC, and resistant to acid, even at pH2, the acid level in the stomach.

In 2014, LiveSpo Global began to export its products to many countries in the world. Since then, they continued to expand their main product line of spore-based liquid probiotic supplements for digestive disorder as well as diversify their categories to a wider range of other products for respiratory, skin care, acne treatment, etc.

LiveSpo Global’s domestic revenue comes from the pharmacy channel and online company’s website. As for export, they promote online sales to the US and Europe via Amazon.com.

Looking forward, LiveSpo Global aims to become a digitalized pharmaceutical company that revolutionizes the way consumers care for health with spore probiotics.

LiveSpo Global is the fourth investee company announced by Mekong Enterprise Fund IV. 

For more information, please visit the firm’s website at livespoglobal.com.